Clario

Clario is a leading healthcare research and technology company founded in 1972. The company's slogan "Transforming Lives by Unlocking Better Evidence" reflects its mission to generate high-quality clinical evidence for pharmaceutical, biotech, and medical device partners. Clario offers comprehensive evidence generation solutions, including eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. With a global team of science, technology, and operational experts, Clario has supported over 26,000 clinical trials in more than 100 countries, contributing to over 60% of all FDA drug approvals since 2019. In October 2019, Clario received a Private Equity Round investment from Novo Holdings, Astorg Partners, and Nordic Capital. This investment is a testament to the company's strong position in the Biotechnology and Pharmaceutical industries. Clario's broad endpoint technologies and deep scientific expertise have established its reputation as a reliable partner for decentralized clinical trials, making it a key player in transforming lives through better evidence generation. For further details, individuals can visit the company's website at Clario.com.